Volume 11, Number 10—October 2005
Research
Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003
Jessica M. Buck*
, Kathryn Como-Sabetti*, Kathleen H. Harriman*, Richard N. Danila*, David J. Boxrud*, Anita Glennen*, and Ruth Lynfield*
, Kathryn Como-Sabetti*, Kathleen H. Harriman*, Richard N. Danila*, David J. Boxrud*, Anita Glennen*, and Ruth Lynfield*Table 4
Distribution of HA-MRSA PFTs among invasive disease and SSTI community-associated MRSA isolates*
| HA-MRSA PFTs | Invasive disease isolates (n = 25), no. (%) | SSTI isolates (n = 99), no. (%) |
|---|---|---|
| USA100 | 17 (28) | 43 (8) |
| USA200 | 3 (5) | 4 (0.8) |
| USA500 | 5 (8) | 40 (7.6) |
| USA600 | 0 | 1 (0.2) |
| USA700 | 0 | 1 (0.2) |
| USA800 | 0 | 10 (2) |
| Total† | 25 (42) | 99 (19) |
*HA, healthcare-associated; MRSA, methicillin-resistant Staphylococcus aureus; PFTs, pulsed-field types; SSTI, skin and soft tissue infection.
†Odds ratio 3.63, 95% confidence interval 2.03–6.50, p<0.001.
